GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
₹2,694.90
arrow_downward
-0.68%(-18.50) 1D
Nov 20, 1:49:34 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
₹2,701.00
High
₹2,732.80
Low
₹2,680.00
Mkt. cap
456.53B
Avg. vol.
94.32K
Volume
30.13K
Dividend
2.12%
Quarterly dividend
₹14.25
Ex-dividend date
May 29, 2026
P/E ratio
39.82
52-wk high
₹3,120.70
52-wk low
₹2,088.10
EPS
₹67.68
Shares outstanding
169.41M
No. of employees
3K
Open
₹2,701.00
High
₹2,732.80
Low
₹2,680.00
Mkt. cap
456.53B
Avg. vol.
94.32K
Volume
30.13K
Dividend
2.12%
Quarterly dividend
₹14.25
Ex-dividend date
May 29, 2026
P/E ratio
39.82
52-wk high
₹3,120.70
52-wk low
₹2,088.10
EPS
₹67.68
Shares outstanding
169.41M
No. of employees
3K
News stories
From web sources and news partners
Investing.com
·
16 minutes ago
S&P 500 Breaks Support as Global Risk Sentiment Begins to Crack
FOREX.com
·
2 hours ago
S&P 500 Analysis: SPX Is Going Through One of Its Most Difficult Periods of 2026
TradingView
·
2 hours ago
Stock Market: Will S&P 500 Open Up or Down Today?
FXEmpire
·
41 minutes ago
S&P 500 and Nasdaq 100 Fall Despite Anthropic IPO Debut
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees3.1K
FoundedNov 13, 1924
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteindia-pharma.gsk.com